Portola Pharma Balance Sheet - Annual (NASDAQ:PTLA)

Add to My Stocks
$27.55 $0.62 (2.2%) PTLA stock closing price Sep 21, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Portola Pharma, and helps in stock analysis. As in our Portola Pharma stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Good annual results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The balance sheet shows total liabilities of $222.18M and shareholders equity of $349.49M. Portola Pharma revenue and Portola Pharma operating cash flow are important in understanding the financial capacity of the company.

View latest 10 year balance sheet data to check Portola Pharma financial performance.
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec20172016201520142013201220112010
Marketable Securities281.58M130.29M257.71M251.75M150.89M77.65M17.76M-
Raw Materials--------
Work In Progress1.03M-------
Finished Goods--------
Notes Receivable--------
Other Current Assets9.74M9.97M20.03M5.74M3.73M2.98M--
Total Current Assets
Property Plant & Equipment17.82M17.05M15.22M10.47M8.75M7.66M7.29M-
Accumulated Depreciation12.6M10.9M8.98M7.7M6.15M4.8M3.41M-
Net Property Plant & Equipment
Investment & Advances71.07M-15.96M83.03M50.37M6.11M--
Other Non-Current Assets--------
Deferred Charges--------
Deposits & Other Assets9.6M5.21M11.99M15.61M-2.11M--
Total Assets
Notes Payable--------
Accounts Payable9.3M14.54M10.27M14.08M3.23M4.84M2.82M-
Current Portion Long-Term Debt--------
Current Portion Capital Leases--------
Accrued Expenses60.05M30.32M32.48M17.47M20.36M9.25M6.87M-
Income Taxes Payable--------
Other Current Liabilities11.16M20.79M8.38M9.56M1.95M4.72M10.69M-
Total Current Liabilities
Deferred Taxes/Income18.79M24.96M18.62M27.01M3.25M-59.54M-
Convertible Debt--------
Long-Term Debt104.81M50.06M------
Non-Current Capital Leases--------
Other Long-Term Liabilities18.04M10.05M2.82M--1.46M2.29M-
Total Liabilities
Minority Interest--------
Preferred Stock-----317.28M317.28M-
Common Stock Net--------
Capital Surplus1.55B1.11B1.08B770.78M581.91M10.71M7.58M-
Retained Earnings-1.2B-918.34M-649.3M-422.79M-285.67M-202.32M-213.68M-
Treasury Stock--------
Other Liabilities2.21M2.14M2.77M-0.23M----
Shareholders Equity349.49M192.68M430.32M347.8M296.33M125.71M111.17M-
Total Liabilities & Shareholders Equity571.67M343.43M502.92M416.49M325.73M146M193.4M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Apart from balance sheet items, an investor would do well to keep track of the Portola Pharma stock price by looking at Portola Pharma historical stock prices. One can compare PE with industry average by looking at the Portola Pharma PE ratio chart. The common balance sheet items are:

  • Assets: An asset is a resource that a corporation like Portola Pharma owns and has monetary significance. PTLA assets grew from $343.43M in 2016 to $571.67M in 2017. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Portola Pharma's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for PTLA stock stand at $222.18M.

Portola Pharma Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio